文献速递疝与腹壁外科围术期管理与 ERAS

病态肥胖患者机器人腹壁疝修补术的围手术期与中期结局

Robotic ventral hernia repair in morbidly obese patients: perioperative and mid-term outcomes.
PubMed 文献 · Surg Endosc · 2019-10-03

术后并发症发生率为46%,最常见为早期持续性疼痛/不适(32%);随访平均22.7个月,疝复发率为2%,平均无复发生存时间为57.4个月(95%CI 54.6-60.2)。结论提示RVHR在病态肥胖患者中安全有效,复发率低且无复发时间长。

要点

  • 病态肥胖患者RVHR术后并发症率为46%,以早期疼痛/不适最常见(32%)。
  • BMI、粘连松解、腹腔内补片放置及离台时间与术后并发症显著相关。
  • 平均随访22.7个月,疝复发率仅2%,无复发生存时间长达57.4个月。

核心结论

  • RVHR在病态肥胖患者中安全有效,复发率低且无复发生存时间长。

主要发现

  • 中位BMI为42.9 kg/m2,离开PACU前中位疼痛评分为4,平均住院时间0.32天。
  • 术后并发症发生率为46%,其中Clavien-Dindo I-II级占40%,III-IV级占6%。
  • 早期术后最常见并发症为持续性疼痛/不适,占32%。
  • 回归分析显示BMI、粘连松解、腹腔内补片放置及离台时间与术后并发症显著相关。
  • 平均随访22.7个月,疝复发率为2%,平均无复发生存时间为57.4个月(95%CI 54.6-60.2)。

关键数值与推荐

  • 病态肥胖定义为BMI≥40 kg/m2。
  • 术后并发症采用Clavien-Dindo分级和综合并发症指数评估,最大CCI评分为42.9。
  • 并发症发生率46%,复发率2%,平均无复发生存时间57.4个月(95%CI 54.6-60.2)。

临床怎么用

  • 对于病态肥胖(BMI≥40 kg/m2)的腹壁疝患者,RVHR可作为安全有效的术式选择。
  • 围手术期应关注BMI、粘连松解、腹腔内补片放置及离台时间等与并发症相关的因素。

局限性

  • 需要进一步研究以阐明机器人手术在病态肥胖患者中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obesity is a growing epidemic and it has been found to be an independent risk factor for a multitude of perioperative complications. We describe our experience with morbidly obese patients who underwent robotic ventral hernia repair (RVHR), examining factors affecting perioperative and mid-term outcomes. METHODS: From a prospectively maintained database, all morbid obese (BMI ≥ 40 kg/m2) patients who underwent robotic procedures between 2013 and 2018 were analyzed retrospectively including perioperative outcomes and the mid-term follow-up. Complications were assessed with validated grading systems and index. Univariate analyses and multivariate logistic regression analysis were performed to determine the factors associated with the development of any complication. Kaplan-Meier's time-to-event analysis was performed to calculate freedom-of-recurrence. RESULTS: Fifty patients with median BMI 42.9 kg/m2 were included. The median last pain score before leaving PACU was 4. The mean LOS of all cohorts was 0.32 day. The postoperative complication rate was 46%. The most frequent complication was persistent pain/discomfort (32%) in early postoperative period. Minor complications (Clavien-Dindo grade-I and II) were seen in 40% of patients while major complications (Clavien-Dindo grade-III and IV) were seen in 6%. The maximum comprehensive complication index® score was 42.9. In regression analysis, BMI, adhesiolysis, intraperitoneal mesh placement, and off-console time were found to be significantly associated with postoperative complications. Mean follow-up was 22.7 months. Hernia recurrence was seen in 2% and the mean freedom-of-recurrence was 57.4 months (95% CI 54.6-60.2). CONCLUSIONS: To our best knowledge, this study is the first to present outcomes of morbidly obese patients who underwent RVHR. The results indicate the safety and efficacy of RVHR in morbid obesity with a low recurrence rate as well as a long freedom-of-recurrence time. Further studies are needed to better elucidate the role of robotic surgery in morbidly obese patients.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Gokcal F, Morrison S, Kudsi OY, et al. Robotic ventral hernia repair in morbidly obese patients: perioperative and mid-term outcomes. Surg Endosc. 2019. PMID: 31583469. doi:10.1007/s00464-019-07142-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。